Serum vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancer

Author: Baccala A.A.   Zhong H.   Clift S.M.   Nelson W.G.   Marshall F.F.   Passe T.J.   Gambill N.B.   Simons J.W.  

Publisher: Elsevier

ISSN: 0090-4295

Source: Urology, Vol.51, Iss.2, 1998-02, pp. : 327-332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract